中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2014年
5期
168-169,206
,共3页
髂内动脉结扎术%导管动脉栓塞术%妇产科%难治性大出血
髂內動脈結扎術%導管動脈栓塞術%婦產科%難治性大齣血
가내동맥결찰술%도관동맥전새술%부산과%난치성대출혈
UAL%TAE%Refractory hemorrhage%Obstetrics and gynecology
目的:比较髂内动脉结扎术(UAL)和导管动脉栓塞术(TAE)治疗难治性产妇大出血的临床效果。方法按照患者意愿将我院收治的92例难治性大出血患者分为TAE组50例和UAL组42例,分别行TAE和UAL治疗,比较两组患者手术时间、术中出血量、术后阴道流血时间、子宫切除率、止血有效率、术后并发症发生率和住院时间。结果 TAE组患者手术时间和止血有效率均明显高于UAL组,术中出血量、术后阴道流血时间、子宫切除率、术后并发症发生率和住院时间均明显低于UAL组,差异具有统计学意义( P<0.05)。结论 TAE治疗难治性大出血止血效果好、术后并发症少、住院时间短、能够最大限度保留患者子宫,可作为治疗难治性大出血的首选术式。
目的:比較髂內動脈結扎術(UAL)和導管動脈栓塞術(TAE)治療難治性產婦大齣血的臨床效果。方法按照患者意願將我院收治的92例難治性大齣血患者分為TAE組50例和UAL組42例,分彆行TAE和UAL治療,比較兩組患者手術時間、術中齣血量、術後陰道流血時間、子宮切除率、止血有效率、術後併髮癥髮生率和住院時間。結果 TAE組患者手術時間和止血有效率均明顯高于UAL組,術中齣血量、術後陰道流血時間、子宮切除率、術後併髮癥髮生率和住院時間均明顯低于UAL組,差異具有統計學意義( P<0.05)。結論 TAE治療難治性大齣血止血效果好、術後併髮癥少、住院時間短、能夠最大限度保留患者子宮,可作為治療難治性大齣血的首選術式。
목적:비교가내동맥결찰술(UAL)화도관동맥전새술(TAE)치료난치성산부대출혈적림상효과。방법안조환자의원장아원수치적92례난치성대출혈환자분위TAE조50례화UAL조42례,분별행TAE화UAL치료,비교량조환자수술시간、술중출혈량、술후음도류혈시간、자궁절제솔、지혈유효솔、술후병발증발생솔화주원시간。결과 TAE조환자수술시간화지혈유효솔균명현고우UAL조,술중출혈량、술후음도류혈시간、자궁절제솔、술후병발증발생솔화주원시간균명현저우UAL조,차이구유통계학의의( P<0.05)。결론 TAE치료난치성대출혈지혈효과호、술후병발증소、주원시간단、능구최대한도보류환자자궁,가작위치료난치성대출혈적수선술식。
Objective To compare the clinical effects of the refractory obstetrics and gynecology hemorrhage by UAL and TAE. Methods 92 cases of patients with refractory obstetrics and gynecology hemorrhage were divided into TAE group(50 cases) and UAL group(42 cases). The operative time, mean bleeding volum, the time of vaginal bleeding after surgery, the rate of hysterectomy, the rate of hemostasis, the rate of complication and the length of stay were compared. Results The operative time and the rate of hemostasis in TAE group were higher than the UAL group (P<0.05), the mean bleeding volum, the time of vaginal bleeding after surgery, the rate of hysterectomy, the rate of complication and the length of stay in TAE group were lower than the UAL group(P<0.05). Conclusion It has good clinical effects, few complication, short hospitalization time, and it can reserving their uterus maximum limit. It can be as the principal choice for the refractory obstetrics and gynecology hemorrhage.